Advertisement

Supply Chain

Dublin, Ireland-based Allergan will purchase Fort Washington, Pa.-based clinical-stage biotechnology company Vitae Pharmaceuticals for $639 million, twice its market value, according to The Wall Street Journal.

The largest driver of high drug costs in the U.S. may be government practices that allow drug companies to develop large monopolies on their products, according to a study featured in the Journal of American Medical Association.

Advertisement

Ajilon Professional Staffing recently conducted a survey that indicated salaries for supply chain executives will increase by 2.9 percent in 2017, a jump from the 2 percent projection for 2016, reported Logistics Management.

The Food and Drug Administration approved the VisuMax Femtosecond Laser for use in a surgical procedure to reduce or eliminate myopia — nearsightedness — in patients.

The Food and Drug Administration recently approved Shire's new drug Cuvitru to treat patients with primary immunodeficiency diseases.

Advertisement